Last 1.03 INR
Change Today -0.02 / -1.90%
Volume 2.0K
As of 4:42 AM 07/28/14 All times are local (Market data is delayed by at least 15 minutes).

mavens biotech ltd (MAVB) Snapshot

Open
1.05
Previous Close
1.05
Day High
1.05
Day Low
1.03
52 Week High
07/4/14 - 1.81
52 Week Low
08/1/13 - 0.40
Market Cap
113.2M
Average Volume 10 Days
38.4K
EPS TTM
0.06
Shares Outstanding
109.9M
EX-Date
09/16/10
P/E TM
16.1x
Dividend
--
Dividend Yield
--
Current Stock Chart for MAVENS BIOTECH LTD (MAVB)

Related News

No related news articles were found.

mavens biotech ltd (MAVB) Related Businessweek News

No Related Businessweek News Found

mavens biotech ltd (MAVB) Details

Mavens Biotech Limited operates as a plant biotechnology company in India. It is engaged in trading agro products and commodities; producing seeds; and manufacturing secondary nutrients and neem based products. The company also operates a bioinformatics center to handle, capture, manage, and analyze various quantities of scientific data; and a plant tissue culture unit to produce a range of plant species, such as ornamental and medicinal plants, banana, and sugarcane. In addition, it is involved in IT activities; and developing projects in the integrated residential township, low cost housing, commercial infrastructure, power generation, and other related infrastructure areas. The company was incorporated in 1981 and is based in New Delhi, India.

Founded in 1981

mavens biotech ltd (MAVB) Top Compensated Officers

Whole Time Director
Total Annual Compensation: 252.0K
Compensation as of Fiscal Year 2013.

mavens biotech ltd (MAVB) Key Developments

Mavens Biotech Limited Reports Audited Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2014

Mavens Biotech Limited reported audited earnings results for the fourth quarter and full year ended March 31, 2014. For the quarter, the company reported net sales/income from operations of INR 71.989 million against INR 116.074 million a year ago. Loss from operations before other income finance cost and exceptional items was INR 2.612 million compared to profit from operations before other income finance cost and exceptional items of INR 0.772 million a year ago. Loss from ordinary activities before tax was INR 2.361 million against profit from ordinary activities before tax of INR 0.889 million a year ago. Net loss was INR 2.361 million compared to net profit of INR 0.889 million a year ago. Basic and diluted loss per share before and after extraordinary items was INR 0.02 against basic and diluted earnings per share before and after extraordinary items INR 0.01 a year ago. For the year, the company reported net sales/income from operations of INR 381.759 million against INR 458.304 million a year ago. Loss from operations before other income finance cost and exceptional items was INR 0.323 million compared to profit from operations before other income finance cost and exceptional items of INR 6.528 million a year ago. Profit from ordinary activities before tax was INR 0.740 million against INR 7.461 million a year ago. Net profit was INR 0.682 million against net profit of INR 7.072 a year ago. Basic and diluted earnings per share before and after extraordinary items was INR 0.01 against INR 0.06 a year ago.

Mavens Biotech Limited to Report Q4, 2014 Results on May 28, 2014

Mavens Biotech Limited announced that they will report Q4, 2014 results on May 28, 2014

Mavens Biotech Limited, Board Meeting, May 28, 2014

Mavens Biotech Limited, Board Meeting, May 28, 2014. Agenda: To adopt the audited financial results for the fourth quarter and full year ended March 31, 2014.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MAVB:IN 1.03 INR -0.02

MAVB Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for MAVB.
View Industry Companies
 

Industry Analysis

MAVB

Industry Average

Valuation MAVB Industry Range
Price/Earnings 100.0x
Price/Sales 0.3x
Price/Book 0.7x
Price/Cash Flow 40.7x
TEV/Sales 0.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MAVENS BIOTECH LTD, please visit www.mavensbiotech.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.